Estrategias para el manejo de los trastornos por consumo de alcohol | 07 OCT 13

Consumo de alcohol en los adultos

Criterios para el diagnóstico y categorización: abuso o dependencia, consecuencias conductuales y fisiológicas. Tratamiento: remisión o recuperación, guías y evidencias para las intervenciones.
Autor/a: Dr. Peter D. Friedmann N Engl J Med 2013;368:365-73.
INDICE:  1.  | 2. Referencias bibliográficas
Referencias bibliográficas

1. Bouchery EE, Harwood HJ, Sacks JJ, Simon CJ, Brewer RD. Economic costs of excessive alcohol consumption in the U.S., 2006. Am J Prev Med 2011;41:516-24.
2. Alcohol-related disease impact (ARDI). Atlanta: Center for Disease Control and Prevention, 2008 (http://www.cdc.gov/ alcohol/ardi.htm).
3. Grant BF, Dawson DA, Stinson FS, Chou SP, Dufour MC, Pickering RP. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug Alcohol Depend 2004;74:223-34.
4. Diagnostic and statistical manual of mental disorders, 4th ed., text revision. Washington, DC: American Psychiatric Association, 2000.
5. National Institute on Alcohol Abuse and Alcoholism. Helping patients who drink too much: a clinician’s guide. Rockville, MD: Department of Health and Human Services, National Institutes of Health, 2007 (http://pubs.niaaa.nih.gov/publications/Practitioner/CliniciansGuide 2005/clinicians_guide.htm).
6. Saha TD, Chou SP, Grant BF. Toward an alcohol use disorder continuum using item response theory: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med 2006;36:931-41.
7. Rehm J, Room R, Graham K, Monteiro M, Gmel G, Sempos CT. The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview. Addiction 2003;98:1209-28.
8. Dawson DA, Li TK, Grant BF. A prospective study of risk drinking: at risk for what? Drug Alcohol Depend 2008;95:62-72.
9. Hasin DS, Fenton MC, Beseler C, Park JY, Wall MM. Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients. Drug Alcohol Depend 2012;122:28-37.
10. Naimi TS, Brown DW, Brewer RD, et al. Cardiovascular risk factors and confounders among nondrinking and moderate- drinking U.S. adults. Am J Prev Med 2005;28:369-73.
11. Bagnardi V, Rota M, Botteri E, et al. Light alcohol drinking and cancer: a metaanalysis. Ann Oncol 2012 August 21 (Epub ahead of print).
12. Dawson DA, Grant BF, Stinson FS, Chou PS, Huang B, Ruan WJ. Recovery from DSM-IV alcohol dependence: United States, 2001-2002. Addiction 2005;100: 281-92.
13. Vaillant GE. A 60-year follow-up of alcoholic men. Addiction 2003;98:1043-51.
14. Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Beekman AT, Penninx BW. Predictors of the 2-year recurrence and persistence of alcohol dependence. Addiction 2012;107:1639-40.
15. Moos RH, Moos BS. Rates and predictors of relapse after natural and treated remission from alcohol use disorders. Addiction 2006;101:212-22.
16. Cohen E, Feinn R, Arias A, Kranzler HR. Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2007;86:214- 21.
17. Smith PC, Schmidt SM, Allensworth- Davies D, Saitz R. Primary care validation of a single-question alcohol screening test. J Gen Intern Med 2009;24:783-8. [Erratum, J Gen Intern Med 2010;25:375.]
18. Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res 2007;31:1208-17.
19. Friedmann PD, Saitz R, Gogineni A, Zhang JX, Stein MD. Validation of the screening strategy in the NIAAA “Physicians’ Guide to Helping Patients with Alcohol Problems.” J Stud Alcohol 2001;62:234-8.
20. Turner BJ, McLellan AT. Methodological challenges and limitations of research on alcohol consumption and effect on common clinical conditions: evidence from six systematic reviews. J Gen Intern Med 2009;24:1156-60.
21. Rubinsky AD, Kivlahan DR, Volk RJ, Maynard C, Bradley KA. Estimating risk of alcohol dependence using alcohol screening scores. Drug Alcohol Depend 2010;108:29-36.
22. Vinson DC, Kruse RL, Seale JP. Simplifying alcohol assessment: two questions  to identify alcohol use disorders. Alcohol Clin Exp Res 2007;31:1392-8.
23. Friedmann PD, Saitz R, Samet JH. Management of adults recovering from alcohol or other drug problems: relapse prevention in primary care. JAMA 1998; 279:1227-31.
24. Rollnick S, Miller WR, Butler CC. Motivational interviewing in health care: helping patients change behavior. New York: Guilford, 2007.
25. Jonas DE, Garbutt JC, Amick HR, et al. Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2012;157:645-54.
26. Field CA, Baird J, Saitz R, Caetano R, Monti PM. The mixed evidence for brief intervention in emergency departments, trauma care centers, and inpatient hospital settings: what should we do? Alcohol Clin Exp Res 2010;34:2004-10.
27. McQueen J, Howe TE, Allan L, Mains D, Hardy V. Brief interventions for heavy alcohol users admitted to general hospital wards. Cochrane Database Syst Rev 2011;8:CD005191.
28. Riper H, Spek V, Boon B, et al. Effectiveness of E-self-help interventions for curbing adult problem drinking: a metaanalysis. J Med Internet Res 2011;13(2):e42.
29. Amato L, Minozzi S, Davoli M. Efficacy and safety of pharmacological interventions for the treatment of the alcohol withdrawal syndrome. Cochrane Database Syst Rev 2011;6:CD008537.
30. Miller WR, Walters ST, Bennett ME. How effective is alcoholism treatment in the United States? J Stud Alcohol 2001;62:211-20.
31. J.rgensen CH, Pedersen B, T.nnesen H. The efficacy of disulfiram for the treatment of alcohol use disorder. Alcohol Clin Exp Res 2011;35:1749-58.
32. Mason BJ, Lehert P. Acamprosate for alcohol dependence: a sex-specific metaanalysis based on individual patient data. Alcohol Clin Exp Res 2012;36:497-508.
33. R.sner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 2010;12:CD001867.
34. Garbutt JC, Kranzler HR, O’Malley SS, et al. Efficacy and tolerability of longacting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA 2005;293:1617-25. [Errata, JAMA 2005;293:1978, 2864.]
35. Ducharme LJ, Knudsen HK, Roman PM. Trends in the adoption of medications for alcohol dependence. J Clin Psychoph rmacol 2006;26:Suppl 1:S13-S19.
36. Anton RF, O’Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 2006;295:2003-17.
37. Johnson BA, Rosenthal N, Capece JA, et al. Topiramate for treating alcohol dependenc e:a randomized controlled trial. JAMA 2007;298:1641-51.
38. Kranzler HR, Feinn R, Armeli S, Tennen H. Comparison of alcoholism subtypes as moderators of the response to sertraline treatment. Alcohol Clin Exp Res 2012;36:509-16.
39. Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA 2004;291:1887-96.
40. Edwards S, Kenna GA, Swift RM, Leggio L. Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review. Curr Pharm Des 2011;17:1323-32.
41. Walitzer KS, Dermen KH, Barrick C. Facilitating involvement in Alcoholics Anonymous during out-patient treatment: a randomized clinical trial. Addiction 2009;104:391-401.
42. Kelly JF, Hoeppner B, Stout RL, Pagano M. Determining the relative importance of the mechanisms of behavior change within Alcoholics Anonymous: a multiple mediator analysis. Addiction 2012;107:289-99.
43. Witbrodt J, Mertens J, Kaskutas LA, Bond J, Chi F, Do Weisner C. Do 12-step meeting attendance trajectories over 9 years predict abstinence? J Subst Abuse Treat 2012;43:30-43.
44. Kirshenbaum AP, Olsen DM, Bickel WK. A quantitative review of the ubiquitous relapse curve. J Subst Abuse Treat 2009;36:8-17.
45. Dawson DA, Goldstein RB, Grant BF. Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up. Alcohol Clin Exp Res 2007;31:2036-45.
46. Kristenson H, Ohlin H, Hultén-Nosslin MB, Trell E, Hood B. Identification and intervention of heavy drinking in middle-aged men: results and follow-up of 24-60 months of long-term study with randomized controls. Alcohol Clin Exp Res 1983;7:203-9.
47. Willenbring ML, Olson DH. A randomized trial of integrated outpatient treatment for medically ill alcoholic men. Arch Intern Med 1999;159:1946-52.
48. Brown RL, Saunders LA, Bobula JA, Mundt MP, Koch PE. Randomized-controlled trial of a telephone and mail intervention for alcohol use disorders: threemonth drinking outcomes. Alcohol Clin Exp Res 2007;31:1372-9.
49. Saitz R. Alcohol screening and brief intervention in primary care: absence of evidence for efficacy in people with dependence or very heavy drinking. Drug Alcohol Rev 2010;29:631-40.
50. Beich A, Thorsen T, Rollnick S. Screening in brief intervention trials targeting excessive drinkers in general practice: systematic review and meta-analysis. BMJ 2003;327:536-42.
51. Soderstrom CA, DiClemente CC, Dischinger PC, et al. A controlled trial of brief intervention versus brief advice for at-risk drinking trauma center patients. J Trauma 2007;62:1102-11.
52. Nilsen P, McCambridge J, Karlsson N, Bendtsen P. Brief interventions in routine health care: a population-based study of conversations about alcohol in Sweden. Addiction 2011;106:1748-56.
53. Bertholet N, Cheng DM, Palfai TP, Saitz R. Factors associated with favorable drinking outcome 12 months after hospitalization in a prospective cohort study of inpatients with unhealthy alcohol use. J Gen Intern Med 2010;25:1024-9.
54. Hasin D. Still difficult to know what alcohol dependent individuals can return to controlled drinking: comments on Dawson et al. (2005). Addiction 2005; 100:295-6.
55. The guide to clinical preventive services 2010–2011: recommendations of the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality, 2010

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024